This, for the first time, suggested that CUR might play a role in inhibiting tumor invasion and migration by blocking the binding of ARHGEF12 and RhoA, which provided a theoretical basis for the CUR treatment of colon cancer. The gene discussed is ARHGEF12; the disease is malignant colon neoplasm.